Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

Authors :: Kahina, Saker
Bruno, Pozzetto
Antonin, Bal
Martine, Valette
Jean Baptiste, Fassier
Carla, Saade
Mary Anne, Trabaud
Sophie, Trouillet-Assant
Camille, Mena
Source :: Clinical chemistry. 68(7)
Publication Year :: 2022

Subjects :: Neutralization Tests
SARS-CoV-2
Biochemistry (medical)
Clinical Biochemistry
Spike Glycoprotein, Coronavirus
COVID-19
Humans
Antibodies, Viral
Antibodies, Neutralizing

Tools